The EULAR Campaigns
EULAR hosts campaigns to help achieve its goal in the area of Advocacy: to increase participation in work by people with RMDs by the year 2023.
Don’t Delay, Connect Today
In 2017, EULAR launched the Europe-wide campaign entitled ‘Don’t Delay, Connect Today’ with the goal to highlight rheumatic and musculoskeletal diseases (RMDs) as major diseases and a public health concern of pandemic proportions and that early diagnosis and timely access to treatment can prevent further damage and burden on the individual and society.
Don't Delay, Connect Today: Time2Work
In 2019, the Don't Delay, Connect Today campaign was given a sub-theme focused on work and RMDs with the strap-line, “Time2Work” with the objective to help people with RMDs access work for the first time, remain in work when they develop an RMD, or return to work after rehabilitation, and to promote the adoption of other initiatives that not only help people with RMDs, but all workers.
Don't Delay, Connect Today: Time2Research
The campaign focuses in motivating higher numbers of people living with Rheumatic and Musculoskeletal Diseases (RMDs) to undergo training to become a PRP and to then take part in the research process. As a result, research will prosper and the new and developing trend toward a highly patient-centric approach to drug discovery and the related legislative and regulatory environment to support this process is enabled.
The campaign journey: Early diagnosis, access to care, access to work, access to research
EULAR Campaign started in 2017 with the purpose of raising awareness around early diagnosis, access to care and the positive impact that this can have on the many millions who are diagnosed and undiagnosed with an RMD in Europe, especially regarding their ability to have a professional life and access to the workforce – and right to remain in work.
The importance of the patient voice is recognized in 2021 as essential to staying up to date with the current legislative push in policy circles to place the patient at the heart of research, most notably the Pharmaceutical Strategy.
The ability to enable the patient voice to take centre stage in the research process will enable better outcomes in drug discovery, enabling more people suffering an RMD to have access to work, and ultimately inspiring more people to be aware of possible symptoms that they may be suffering and to therefore seek medical advice for possible diagnosis – and access to timely and adequate care.
EULAR Campaign - related events
Join the conversation on social media
For more information contact email@example.com
The EULAR PARE Community
EULAR PARE is the network of national organisations of People with Arthritis/Rheumatism across Europe, united to ensure the voice of people with rheumatic and musculoskeletal diseases (RMDs) is heard and has influence among decision makers within Europe, and create powerful alliances that will make a difference to their lives.
EULAR PARE events platform
EULAR PARE offers a series of sessions and webinars to share latest information and best practice within the community.
Watch the sessions around the campaigns held at previous editions at the EULAR European Congress of Rheumatology.
[to be hyperlinked]